Antony Mattessich | President and Chief Executive Officer |
Donald Notman | Chief Financial Officer |
Scott Corning | Senior Vice President, Commercial |
Michael Goldstein | Chief Medical Officer |
Adnan Butt | Guggenheim Securities |
Dan Leone | Raymond James |
Good afternoon, ladies and gentlemen, thank you for standing by. And welcome to the Ocular Therapeutix Fourth Quarter and Year End 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. It is now my pleasure to turn the call over to Donald Notman, Chief Financial Officer of Ocular Therapeutix.